News

AstraZeneca receives CDSCO approval for Durvalumab, a new treatment for muscle-invasive bladder cancer in India. This marks a ...
Discover a study exploring novel drug combinations and genetic insights transforming advanced bladder cancer treatment.
England's National Health Service will soon offer nivolumab as a quick injection for cancer patients. This new method cuts ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun ...
DelveInsight's, “Oncolytic Virus Cancer Therapy Pipeline Insight, 2025,” report provides comprehensive insights about 120+ companies and 125+ pipeline drugs in Oncolytic Virus Cancer Therapy pipeline ...
A clinical trial is launching to test the effectiveness of new tests that aim to detect genetic signatures of cancer in the ...
Coleen Nolan's brother Brian appeared on Loose Women to share an update on his battle with cancer, just months after being ...
Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...
AstraZeneca secures CDSCO approval to import Durvalumab for muscle-invasive bladder cancer treatment in India.
Former Sky News presenter Dermot Murnaghan has shared that his cancer diagnosis was a "wake-up call" for him. The 67-year-old ...
A national pilot study designed to determine if blood tests can help detect cancers earlier is open for enrollment.Results of ...
Former Sky News presenter Dermot Murnaghan has said he “fell through the gaps” and had a “wake-up call” after receiving his ...